Abstract
BackgroundThe efficacy and adeptness of ChatGPT 3.5 and ChatGPT 4.0 in the precise diagnosis and management of conditions like atopic dermatitis and Autoimmune blistering skin diseases (AIBD) remain to be elucidated. So this study examined the accuracy and effectiveness of the ChatGPT responses related to understanding, therapies, and specific cases of these two conditions. MethodFirstly, the responses provided by ChatGPTs to a set of 50 questionnaires underwent evaluation by five distinct dermatologists, with complete adjudication of the third-party reviewer. The comparative analysis included the evaluative efficacy of both ChatGPT3.5 and ChatGPT4.0 against the diagnostic abilities exhibited by three distinct cohorts of qualified clinical professionals. And then, an examination was conducted to assess the diagnostic proficiency of ChatGPT3.5 and ChatGPT4.0 in the context of diagnosing specific instances of skin blistering autoimmune diseases. ResultsIn assessing the proficiency of ChatGPTs in generating responses related to fundamental knowledge about AD it is noteworthy that both versions of ChatGPTs, despite their lack of specialized training on medical databases, exhibited a commendable capacity to yield solutions that exhibited a substantial degree of concurrence with evidence-based medical information. Accordingly we observed that the performance of ChatGPT-4.0 beyond that of the ChatGPT-3.5. However, it it crucial to emphasize that ChatGPT-4.0 did not show the ability to offer answers surpassing those provided by associate senior, and senior medical professionals. In the assessment designed to determine the proficiency of ChatGPTs in recognizing particular type of AIBD, it is evident that both ChatGPT-4 and ChatGPT-3.5 demonstrated inadequacy in providing responses that are both precise and accurate for each individual occurrence of this skin condition. ConclusionBoth ChatGPT-3.5 and ChatGPT-4.0 satisfactory for addressing fundamental inquiries related to atopic dermatitis, however they prove insufficient for diagnosing AIBD. The progress of ChatGPT in achieving utility within the professional medical domain remains a considerable journey ahead.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
